KR900007429A - 네오글리코프로테인, 이의 제조방법 및 이를 함유하는 제제 - Google Patents

네오글리코프로테인, 이의 제조방법 및 이를 함유하는 제제

Info

Publication number
KR900007429A
KR900007429A KR1019890015922A KR890015922A KR900007429A KR 900007429 A KR900007429 A KR 900007429A KR 1019890015922 A KR1019890015922 A KR 1019890015922A KR 890015922 A KR890015922 A KR 890015922A KR 900007429 A KR900007429 A KR 900007429A
Authority
KR
South Korea
Prior art keywords
neoglycoprotein
preparation
preparations containing
containing same
neoglycoproteins
Prior art date
Application number
KR1019890015922A
Other languages
English (en)
Other versions
KR0162635B1 (ko
Inventor
비간트 헤르베르트
보슬렛 질크
보슬렛 클라우스
하랄트 제드라세크 한스
Original Assignee
베링베르크 아크티엔게젤샤프트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 베링베르크 아크티엔게젤샤프트 filed Critical 베링베르크 아크티엔게젤샤프트
Publication of KR900007429A publication Critical patent/KR900007429A/ko
Application granted granted Critical
Publication of KR0162635B1 publication Critical patent/KR0162635B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001169—Tumor associated carbohydrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
KR1019890015922A 1988-11-05 1989-11-03 네오글리코프로테인, 이의 제조방법 및 이를 함유하는 제제 KR0162635B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3837623A DE3837623A1 (de) 1988-11-05 1988-11-05 Neoglykoproteine, ihre herstellung und verwendung
DEP3837623.7 1988-11-05

Publications (2)

Publication Number Publication Date
KR900007429A true KR900007429A (ko) 1990-06-01
KR0162635B1 KR0162635B1 (ko) 1998-11-16

Family

ID=6366580

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890015922A KR0162635B1 (ko) 1988-11-05 1989-11-03 네오글리코프로테인, 이의 제조방법 및 이를 함유하는 제제

Country Status (12)

Country Link
EP (1) EP0368131B1 (ko)
JP (1) JP2838147B2 (ko)
KR (1) KR0162635B1 (ko)
AT (1) ATE142229T1 (ko)
AU (1) AU630634B2 (ko)
CA (1) CA2002218C (ko)
DE (2) DE3837623A1 (ko)
DK (1) DK549589A (ko)
ES (1) ES2093612T3 (ko)
GR (1) GR3021111T3 (ko)
IE (1) IE76312B1 (ko)
PT (1) PT92187B (ko)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3840044A1 (de) * 1988-11-27 1990-06-07 Behringwerke Ag Glykosphingolipide mit kopplungsfaehiger gruppe im sphingoidanteil, ihre herstellung und verwendung
EP0646377A1 (en) * 1993-10-01 1995-04-05 LUANFARMA S.r.l. Albumin-conjugated tumour cell-free extracts, antigenic compositions comprising the same, related antibodies, and uses thereof
US5612030A (en) 1995-01-17 1997-03-18 University Of Kentucky Research Foundation Anti-idiotype monoclonal antibody 1A7 and use for the treatment of melanoma and small cell carcinoma
US5977316A (en) * 1995-01-17 1999-11-02 The Board Of Trustees Of The University Of Kentucky Monoclonal antibody 1A7 and related polypeptides
US5935821A (en) 1995-01-17 1999-08-10 Board Of Trustees Of The University Of Kentucky Polynucleotides related to monoclonal antibody 1A7 and use for the treatment of melanoma and small cell carcinoma
WO1997003701A2 (en) 1995-07-14 1997-02-06 Glycotech Corp. Compounds and methods for treatment of egf receptor associated cancers and purification of the egf receptor
US6355244B1 (en) 1997-11-17 2002-03-12 University Of Kentucky Research Foundation Methods and compositions for the treatment of psoriasis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4557931A (en) * 1982-12-02 1985-12-10 Regents Of The University Of California Antigenic compositions and methods for using same
DE3840044A1 (de) * 1988-11-27 1990-06-07 Behringwerke Ag Glykosphingolipide mit kopplungsfaehiger gruppe im sphingoidanteil, ihre herstellung und verwendung

Also Published As

Publication number Publication date
EP0368131A2 (de) 1990-05-16
ES2093612T3 (es) 1997-01-01
DE3837623A1 (de) 1990-05-10
PT92187A (pt) 1990-05-31
DE58909720D1 (de) 1996-10-10
AU630634B2 (en) 1992-11-05
CA2002218A1 (en) 1990-05-05
IE893548L (en) 1990-05-05
DK549589A (da) 1990-05-06
GR3021111T3 (en) 1996-12-31
KR0162635B1 (ko) 1998-11-16
ATE142229T1 (de) 1996-09-15
AU4436889A (en) 1990-05-10
DK549589D0 (da) 1989-11-03
JP2838147B2 (ja) 1998-12-16
PT92187B (pt) 1995-06-30
CA2002218C (en) 2000-08-08
IE76312B1 (en) 1997-10-22
EP0368131A3 (en) 1990-12-19
EP0368131B1 (de) 1996-09-04
JPH02173000A (ja) 1990-07-04

Similar Documents

Publication Publication Date Title
DE69329538D1 (de) Chlorophyll- und Bakteriochlorophyll-Derivate, ihre Herstellung und diese enthaltende pharmazeutische Zubereitungen
NO831317L (no) Fremgangsmaate for fremstilling av funksjonelle menneske-urokinase proteiner.
NO872966D0 (no) Fremgangsmaate for fremstilling av granulocyttstimulerende preparater.
DK165112C (da) 2,2'-iminobisethanolderivater, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende disse
DK0733067T3 (da) N-terminalt kemisk modificerede proteinpræparater og fremgangsmåder
FI104255B1 (fi) Menetelmä ihmisen seerumialbumiinin N-terminaalifragmentteja sisältävien fuusioproteiinien valmistamiseksi
DK614987D0 (da) Syntetiske htlv-iii peptider, praeparater og anvendelser deraf
DE68922338D1 (de) Entfernung von Protein A aus Antikörper-Präparationen.
NO862096L (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater inneholdende vevsplasminogenaktivator.
KR900007429A (ko) 네오글리코프로테인, 이의 제조방법 및 이를 함유하는 제제
NO870476L (no) Fremgangsmaate for fremstilling av kryss-beskyttende humane monoklonale antistoffpreparater.
ES547051A0 (es) Procedimiento para obtener complejos fviii-vwf para uso te- rapeutico
SE8404283L (sv) Anvendning av ett specifikt tumorassocierat antigen, nemligen sialosyllaktotetraos, for diagnostiska och terapeutiska forfaranden vid cancersjukdomar
ATE160359T1 (de) Antigene regionen von tumorfreigestzten partikeln (tlp) komplexen und antikörper die sie erkennen.
DK494088A (da) 4-oxo-3-quinolincarboxylsyrer, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende disse
DK520086A (da) Fremgangsmaade til delvis oprensning af et biologisk aktivt protein, herunder tumornekrosefaktor, samt det herved produkt og pharmaceutisk praeparat indeholdende samme
DK493988D0 (da) 4-oxo-3-quinolincarboxylsyrer, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende disse forbindelser
DE3751597D1 (de) Verwendung von 15-Deoxyspergualin als Arzneimittel.
DK299590D0 (da) Phospholipidderivater, fremgangsmaade til deres fremstilling og terapeutiske praeparater indeholdende disse
IT1192016B (it) Procedimento perfezionato per la confezione di libri composti di segnature cucite
AU5752490A (en) A novel tumor associated antigen
DK26591A (da) Cytidin-5'-diphosphatalkanoler og -glyceroler, fremgangsmaade til fremstilling heraf og praeparater indeholdende disse forbindelser
AU5790390A (en) A novel tumor associated antigen
NO883674D0 (no) 5-hydroksy-3-aminokroman-forbindelser, fremgangsmaater for deres fremstilling, farmasoeytiske preparater inneholdende disse forbindelsene og metoder for behandling dermed.
NO883663L (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee